相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
Hong Qiu et al.
CANCER RESEARCH (2023)
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
Richard Cathomas et al.
EUROPEAN UROLOGY (2022)
Integrated proteogenomic characterization of urothelial carcinoma of the bladder
Ning Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial
Syed A. Hussain et al.
LANCET ONCOLOGY (2022)
Copper-induced cell death Excess copper causes mitochondrial protein aggregation and triggers a distinct form of cell death
Martha A. Kahison et al.
SCIENCE (2022)
Copper induces cell death by targeting lipoylated TCA cycle proteins
Peter Tsvetkov et al.
SCIENCE (2022)
Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
Xiaochen Qi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance
Maria Rosaria Ruocco et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Valentina Oliveri
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
Zhen Zhang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
Liuqing Yang et al.
FRONTIERS IN GENETICS (2022)
Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer
Lijiang Gu et al.
CANCERS (2022)
Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
Zhong-Hao Ji et al.
FRONTIERS IN ONCOLOGY (2022)
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Yuchen Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Connecting copper and cancer: from transition metal signalling to metalloplasia
Eva J. Ge et al.
NATURE REVIEWS CANCER (2022)
Downregulation of PPAR alpha mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells
Jingkui Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Copper metabolism as a unique vulnerability in cancer
Vinit C. Shanbhag et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
TGFβ biology in cancer progression and immunotherapy
Rik Derynck et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer
Ramon Gonzalez Manzano et al.
BMC CANCER (2021)
Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma
Hao Yuan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells
Gang Xue et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Phosphorylation of the androgen receptor at Ser81 is co-sustained by CDK1 and CDK9 and leads to AR-mediated transactivation in prostate cancer
XinTao Gao et al.
MOLECULAR ONCOLOGY (2021)
Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating increment NP63 by sponging miR-762
Tianyao Liu et al.
CELL DEATH & DISEASE (2020)
Long non-coding RNA in bladder cancer
Yuepeng Cao et al.
CLINICA CHIMICA ACTA (2020)
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Michael A. Badgley et al.
SCIENCE (2020)
Dysregulation of Redox Status in Urinary Bladder Cancer Patients
Edyta Reszka et al.
CANCERS (2020)
Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma
Lei Lyu et al.
FRONTIERS IN ONCOLOGY (2020)
TGF-β suppresses type 2 immunity to cancer
Ming Liu et al.
NATURE (2020)
Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysis
Jun-Lin Lu et al.
CANCER MEDICINE (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
Pierre Lelievre et al.
CANCERS (2020)
The updated landscape of tumor microenvironment and drug repurposing
Ming-Zhu Jin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The molecular machinery of regulated cell death
Daolin Tang et al.
CELL RESEARCH (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Jake R. Conway et al.
GENOME MEDICINE (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Landmarks in the treatment of muscle-invasive bladder cancer
Niyati Lobo et al.
NATURE REVIEWS UROLOGY (2017)
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
Petros Fessas et al.
SEMINARS IN ONCOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Serum Copper and Zinc Levels Among Iranian Colorectal Cancer Patients
Zahra Khoshdel et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
Systematic pan-cancer analysis of tumour purity (vol 6, 8971, 2015)
Dvir Aran et al.
NATURE COMMUNICATIONS (2016)
Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine
S Kageyama et al.
CLINICAL CHEMISTRY (2004)
Contemporary management of stage T1 transitional cell carcinoma of the bladder
MS Soloway et al.
JOURNAL OF UROLOGY (2002)